Covered recipient · General Payments record
DANIELA ALEJANDRA ZUNIGA SALAZAR
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2024
$349.87
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $349.87 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | $109.15 | 5 |
| Lilly USA, LLC | $85.93 | 3 |
| Amgen Inc. | $52.61 | 3 |
| Medtronic, Inc. | $24.60 | 1 |
| Sandoz Inc. | $24.53 | 1 |
| Tandem Diabetes Care, Inc. | $23.13 | 1 |
| CHIESI USA, INC. | $15.64 | 1 |
| Radius Health, Inc. | $14.28 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $349.87 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $17.03 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116225566 | CMS |
| Amgen Inc. | $16.35 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116225571 | CMS |
| Amgen Inc. | $19.23 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116225576 | CMS |
| Chiesi USA, Inc. | $15.64 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151842275 | CMS |
| Lilly USA, LLC | $32.78 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135623501 | CMS |
| Lilly USA, LLC | $28.82 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135600747 | CMS |
| Lilly USA, LLC | $24.33 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135562806 | CMS |
| Medtronic, Inc. | $24.60 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116858243 | CMS |
| Radius Health, Inc. | $14.28 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090013322 | CMS |
| Sandoz Inc. | $24.53 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089364651 | CMS |
| Tandem Diabetes Care, Inc. | $23.13 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138742481 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.43 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144623991 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.11 | 09/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144623985 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.48 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144623993 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.60 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144623987 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.53 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144623989 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.